Annual/Quarterly Reports Summary
The financials of the company show a positive trend in revenue growth over the past three years, with revenues increasing to $9,654.4 million in 2023. This growth is attributed to...
February 14, 2024 GPN -1.53%
American Water Works Co. Inc. (AWK) Investor Alert: Key Takeaways From Their Latest Financial Filing
February 14, 2024 AWK -0.88%
The company's revenue growth has been affected by increasing competition, including biosimilars and generics. They rely on discovering, developing, and commercializing innovative products, as well as acquiring or collaborating on...
February 14, 2024 AMGN -2.90%
Occidental's financials show that operating expenses have increased, reflecting rising ongoing costs. The company's net income margin has improved compared to the previous period, but it is not mentioned how...
February 14, 2024 OXY -2.51%
EQT has been facing challenges in revenue growth due to third-party supply chain constraints and curtailments caused by lower natural gas prices. These factors have affected sales volume and...
February 14, 2024 EQT -3.34%
Wabtec has experienced positive revenue growth over the past three years, driven by increased sales in locomotive modernizations, parts, and international locomotive sales. Operating expenses have increased due to restructuring...
February 14, 2024 WAB -1.41%
The context information provided includes details about AIG 's financials, management discussion and analysis, key performance indicators (KPIs), risk assessment, corporate governance and sustainability, and forward guidance. In terms...
February 14, 2024 AIG -0.85%
Eastman has seen a decrease in revenue growth over the past three years due to lower sales volume and selling prices, as well as a deceleration of demand and customer...
February 14, 2024 EMN -1.66%
Cognizant's revenue growth has been declining due to reduced demand and weakness in the banking sector. However, there has been growth in certain segments, thanks to recent acquisitions. Operating expenses...
February 14, 2024 CTSH -0.12%